MENU
KURA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Kura Oncology (KURA) Ownership - Who owns Kura Oncology?
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
12730 High Bluff Drive
Phone
+1 858 500-8800
Employees
142
Web
https://www.kuraoncology.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
515.22M
P/E Ratio
N/A
Total Cash
727.4M
Projected Growth
N/A
Total Debt
16.59M
Revenue
53.88M
Risk (Beta)
0.35
Dividend Yield
N/A
Total Cash/Share
9.01
Total Debt/Equity
N/A
Revenue/Share
0.63 USD as % of share price
Fundamentals
KURA
Capitalization
515M
P/E Ratio
N/A
Risk (Beta)
0.35
Dividend Yield
N/A
Total Cash
727M
Total Cash/Share
9.01
Total Debt
16.6M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.63%
Revenue
53.9M
ROE
N/A
Book Value
414M
P/B Ratio
1.29
Cash Flow
N/A
Earnings
-2.02
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
8K
Current Ratio
9.46
Current Revenue Per Employee
280640.62
Dividends Per Share - Security
N/A
EBITDA
-169.5M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-28.78
Shares Held By Institutions
961M
Shares Outstanding - Current
80.8M
Total Liabilities
347M
Total Volume MTD
N/A
Value
1
Gain YTD
-24.225
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a provider of biopharmaceutical services
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
12730 High Bluff Drive
Phone
+1 858 500-8800
Employees
142
Web
https://www.kuraoncology.com